News center - innovative research and development of high-quality biopharmaceuticals - commercialization of innovative biopharmaceuticals - overseas commercialization of biopharmaceuticals - official website of Kexing Biopharmaceuticaljinnianhui金年会生物制药股份有限公司

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Breaking News! Kexing Biopharm Teams Up with ANTIV to Develop Oral Antiviral Drugs for COVID-19
2022-02-21

2022-02-21

Oral COVID-19 Drugs - the Last Piece of the Puzzle
Kexing Biopharm Granted Exclusive Commercialization License for Overseas Marketing of TOT BIOPHARM's Bevacizumab
2022-01-11

2022-01-11

On January 11, 2022, Kexing Biopharmaceutical Co., Ltd. (stock code: 688136.SH, hereinafter referred to as Kexing Biopharm) and TOT BIOPHARM (hereinafter referred to as Suzhou TOT BIOPHARM)...
Kexing Biopharm Wins Two Golden Bull Awards for Listed Companies
2021-12-20

2021-12-20

On December 20, the list of winners of the 23rd (2020) Golden Bull Award for Listed Companies, hosted by China Securities Journal, was officially released. Kexing Biopharm claimed two awards, the 2020 Golden Bull Science and Technology Innovation Award and the 2020 Golden Bull Enterprise Leadership Award.
Chairman of Kexing Biopharm Deng Xueqin Awarded the First Honorary Fellowship of the Chinese University of Hong Kong, Shenzhen
2021-12-17

2021-12-17

On the morning of December 16, the Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), awarded the First Honorary Fellowship to the following four outstanding individuals in recognition of their remarkable achievements in their respective professional fields and their significant contributions to the university and society.
Kexing Biopharm Awarded the Title of "All-involvement Innovation Enterprise in Jinan City"and“Champion Project of Manufacturing Industry in Shandong Province”
2021-12-09

2021-12-09

Recently, the Department of Industry and Information Technology of Shandong Province and Jinan Municipal Federation of Trade Unions announced that Kexing Biopharm had been awarded the title of "All-involvement Innovation Enterprise in Jinan City".

1 2 3 4 5

TOP

Information for medical professionals only.
Internet Drug Information Service Certificate Number: (Lu)-non-commercial-2018-0066

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation